A NOVEL MODEL

VC Led

Model derived from deep buy-side & corporate development experience, including Australia’s largest digital health growth company IPO.

Working backwards

Programs are designed to address the most common gaps arising when assessing digital health investment opportunities from both VC & enterprise customer perspectives.

Control of funds

Advisory teams determine where funding should be deployed for maximum effect & commercial impact.

No-Equity & Non-Profit

No set valuations & no conflict of interest when advising on go/ no-go decisions. No passive commercial gain for industry partners. If members do not participate, they do not benefit.

Not about “start-ups”

Focus and proven ability to scale and commercialise the existing pipeline and improve the ecosystem to create a better “flow through the funnel”.

ANDHealth has grown from its initial ambition to run a two-year pilot of its flagship ANDHealth+ program by industry growth centre MTPConnect, to running programs across multiple states, with eight program partners, across all stages of development. We have proven our ability to both increase and mature the pipeline of high growth potential digital health companies in Australia and have facilitated significant international networks via our industry development activities. ANDHealth is the leading resource in Australia for best practice commercialisation support and advice in digital health.

The pilot of our flagship ANDHealth+ program selected 10 companies from more than 150 applications, which were then screened by our multi-sectoral, C-suite member panel. Those companies then participated in a globally unique deep industry immersion and advisory program which delivered tailored support and advice specific to their needs and business strategy. Unlike other programs, ANDHealth+ is not curriculum-based but involves a tailored, multi-disciplinary, multi-sector panel of C-suite executives advising and supporting the company across all aspects of its business for up to nine months.

The ANDHealth+ program has delivered outcomes which are internationally competitive and which demonstrate extraordinary impact. Our 10 cohort companies have gone on to deliver exceptional commercial outcomes, raising advice in digital health.

Harness the Collective Cross-sectoral & multi-disciplinary speakers & advisory teams. Proven track records: Product development, or Commercial Agreement at Scale, or Significant Capital Raising.

AUD$30.5 million in new capital, creating 188 new jobs and generating AUD$14.8 million in new revenues. They have undertaken 33 clinical studies of their innovative products across the world. And – most importantly – more than 71,000 patients have so far benefited from these Australian digital health technologies, all in less than three years.